"Preventing Perinatal HIV Infection: Costs and Effects of a Recommended Intervention in the U.S."

According to an abstract submitted by the authors to the 11th International Conference on AIDS, held July 7-12, 1996, in Vancouver, British Columbia, "Objectives: To calculate the national costs of implementing U.S. Public Health Service (PHS) guidelines to reduce perinatal HIV infection through voluntary counseling and testing of pregnant women and treatment of infected mothers and their infants with zidovudine (ZDV), and to compare these costs with the medical cost-savings from pediatric infections prevented. Methods: Cost and cost-effectiveness analyses. The outcome measures are the number of infections prevented by the intervention and the net cost (i.e., the cost...

Want to see the full article?

• Purchase this article for only $3.00